| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Memoona Nasir, Ruth Obrocki, Magdalini Krommyda, Naveed Male. Conus medullaris syndrome as a presenting feature of MOG-associated disease. Practical neurology. 2023-01-13. PMID:36639247. |
mr imaging showed an abnormality in the lowest part of the spinal cord as a first presentation of myelin oligodendrocyte glycoprotein (mog)-associated disease. |
2023-01-13 |
2023-08-14 |
Not clear |
| Francesca Bosello, Damiano Marastoni, Francesca Benedetta Pizzini, Chiara Zaffalon, Andrea Zuliani, Giulia Turri, Sara Mariotto, Erika Bonacci, Emilio Pedrotti, Massimiliano Calabres. Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review. Journal of neuroimmunology. vol 375. 2023-01-09. PMID:36621074. |
we describe the case of a 74 years-old patient who developed a myelin oligodendrocyte glycoprotein (mog) antibody-associated unilateral retrobulbar optic neuritis a few weeks after paucisymptomatic covid-19 disease and, subsequently, after the resolution of the optic neuritis, an acute inflammatory demyelinating polyneuropathy. |
2023-01-09 |
2023-08-14 |
Not clear |
| Wenjing Song, Yang Yao, Heling Zhang, Xin Hao, Liping Zhou, Zhixiao Song, Tiantian Wei, Tianyan Chi, Peng Liu, Xuefei Ji, Libo Zo. Sigma-1 Receptor Activation Improves Oligodendrogenesis and Promotes White-Matter Integrity after Stroke in Mice with Diabetic Mellitus. Molecules (Basel, Switzerland). vol 28. issue 1. 2023-01-08. PMID:36615583. |
only pre084 treatment for 21 d could improve this white-matter injury; increase axon and myelin density; decrease demyelination; and increase the expressions of myelin regulator 2'-3'-cyclic nucleotide 3'-phosphodiesterase (cnpase) and myelin oligodendrocyte protein (mog) (which was expressed by mature oligodendrocytes), the number of nerve/glial-antigen 2 (ng2)-positive cells, and the expression of platelet-derived growth factor receptor-alpha (pdgfrα), all of which were expressed by oligodendrocyte progenitor cells in mice with diabetes and focal cerebral ischemia. |
2023-01-08 |
2023-08-14 |
mouse |
| Alanood E Elterefi, Mahfoud Y Elbashari, Amani Alzaabi, Mohamed E Abouelnaga, Hesham Eiss. Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies. Cureus. vol 14. issue 12. 2023-01-05. PMID:36601183. |
combined central and peripheral demyelination in a patient of multifocal motor neuropathy and positive anti-myelin oligodendrocyte glycoprotein (mog) antibodies. |
2023-01-05 |
2023-08-14 |
Not clear |
| Alanood E Elterefi, Mahfoud Y Elbashari, Amani Alzaabi, Mohamed E Abouelnaga, Hesham Eiss. Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies. Cureus. vol 14. issue 12. 2023-01-05. PMID:36601183. |
myelin oligodendrocyte glycoprotein (mog) antibodies have been identified in central nervous system inflammatory demyelinating disorders (mog antibody disease), inclusive of optic neuritis, transverse myelitis, or acute disseminated encephalomyelitis. |
2023-01-05 |
2023-08-14 |
Not clear |
| Michael Quagliata, Francesca Nuti, Feliciana Real-Fernandez, Kalina Kirilova Kirilova, Federica Santoro, Alfonso Carotenuto, Anna Maria Papini, Paolo Rover. Glucopeptides derived from myelin-relevant proteins and hyperglucosylated non-typeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: a step forward in the identification of native autoantigens in multiple sclerosis. Journal of peptide science : an official publication of the European Peptide Society. 2023-01-04. PMID:36597597. |
we prepared two glucosylated peptides derived from the human myelin proteins, i.e., oligodendrocyte-myelin glycoprotein (omgp) and reticulon-4 receptor (rtn4r), selected by a bioinformatic approach for their conformational homology with csf114(glc), a designed β-turn antigenic probe derived from myelin oligodendrocyte glycoprotein (mog), a glycoprotein present in the cns. |
2023-01-04 |
2023-08-14 |
human |
| Debananda Sahoo, Anil Dash, Anupam Dey, Sujata Dev. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated longitudinally extensive transverse myelitis (LETM) and primary Sjogren syndrome: a rare association. BMJ case reports. vol 15. issue 12. 2023-01-03. PMID:36593613. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated longitudinally extensive transverse myelitis (letm) and primary sjogren syndrome: a rare association. |
2023-01-03 |
2023-08-14 |
Not clear |
| Nazeer Ahmed, Jaya Kumari, Warda Shahnawaz, Hafsa Sami, Fnu Naina, Mohammad Hasan, Sheeza Eru. A unilateral FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) case from a developing country: A case report. Annals of medicine and surgery (2012). vol 84. 2022-12-30. PMID:36582878. |
the new clinical and radiological entity of the myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is known as the flames syndrome. |
2022-12-30 |
2023-08-14 |
Not clear |
| B Thomas Bäckströ. A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis. Journal of visualized experiments : JoVE. issue 190. 2022-12-26. PMID:36571423. |
although animal models do not accurately mimic all of these contrasting human disease phenotypes, there are eae models that reflect some of the different clinical manifestations of ms. for example, myelin oligodendrocyte glycoprotein (mog)-induced eae in c57bl/6j mice mimics human ppms, while myelin proteolipid protein (plp)-induced eae in sjl/j mice resembles rrms. |
2022-12-26 |
2023-08-14 |
mouse |
| Naoki Yamamoto, Hajime Ikenouchi, Yoshiki Takai, Kaoru Endo, Masashi Aok. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease With False-Positive Results in SARS-CoV-2 Antigen Tests: A Case Report. Cureus. vol 14. issue 11. 2022-12-21. PMID:36540506. |
due to positive serum and cerebrospinal fluid myelin oligodendrocyte glycoprotein (mog) antibodies, we made the diagnosis of mog-associated disease. |
2022-12-21 |
2023-08-14 |
Not clear |
| Sara CartaÁlvaro Cobo Calvo, Thaís Armangué, Albert Saiz, Christian Lechner, Kevin Rostásy, Markus Breu, Matthias Baumann, Romana Höftberger, Ilya Ayzenberg, Carolin Schwake, Maria Sepulveda, Eugenia Martínez-Hernández, Gemma Olivé-Cirera, Georgina Arrambide, Mar Tintoré, Raphael Bernard-Valnet, Renaud A Du Pasquier, Fabienne Brilot, Sudarshini Ramanathan, Kathrin Schanda, Alberto Gajofatto, Sergio Ferrari, Elia Sechi, Eoin P Flanagan, Sean J Pittock, Vyanka Redenbaugh, Markus Reindl, Romain Marignier, Sara Mariott. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study. Neurology. 2022-12-16. PMID:36526426. |
although the diagnosis of myelin oligodendrocyte glycoprotein antibody associated disease (mogad) is based on serum mog antibodies (mog-abs) positivity, patients with coexisting or restricted mog-abs in the csf have been reported. |
2022-12-16 |
2023-08-14 |
Not clear |
| Jorge Guzmán, Francisco Vera, Bernardita Soler, Reinaldo Uribe-San-Martin, Lorena García, Adolfo Del-Canto, Andrea Schlatter, Mauricio Salazar, Fernando Molt, Karla Ramirez, José Marín, Carolina Pelayo, Juan Pablo Cruz, Sebastián Bravo-Grau, Claudia Cárcamo, Ethel Ciamp. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) in Chile: lessons learned from challenging cases. Multiple sclerosis and related disorders. vol 69. 2022-12-15. PMID:36521387. |
anti-myelin oligodendrocyte glycoprotein (mog) antibody associated disease (mogad) is an emerging disorder recognized as a clinical entity distinct from multiple sclerosis and aquaporin-4-positive neuromyelitis optica spectrum disorders (nmosd-aqp4+), and its phenotypic spectrum continues to expand. |
2022-12-15 |
2023-08-14 |
Not clear |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Jens Wuerfel, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Dagoberto Callegaro, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Alex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Proebstel, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Luca Carmisciano, Maria Pia Sormani, Frederik Barkhof, Nicola De Stefano, Olga Ciccarell. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults. Brain : a journal of neurology. 2022-12-14. PMID:36515653. |
mri and clinical features of myelin oligodendrocyte glycoprotein (mog)-antibody disease may overlap with those of other inflammatory demyelinating conditions posing diagnostic challenges, especially in non-acute phases and when serologic testing for mog-antibodies is unavailable or shows uncertain results. |
2022-12-14 |
2023-08-14 |
Not clear |
| Yi-Long Wang, Meng-Ying Zhu, Zhe-Feng Yuan, Xiao-Yan Ren, Xiao-Tong Guo, Yi Hua, Lu Xu, Cong-Ying Zhao, Li-Hua Jiang, Xin Zhang, Guo-Xia Sheng, Pei-Fang Jiang, Zheng-Yan Zhao, Feng Ga. Proteomic profiling of cerebrospinal fluid in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. World journal of pediatrics : WJP. 2022-12-12. PMID:36507981. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is an autoimmune demyelinating disorder of the central nervous system. |
2022-12-12 |
2023-08-14 |
Not clear |
| Antonio Luca Spiezia, Antonio Carotenuto, Aniello Iovino, Marcello Moccia, Matteo Gastaldi, Rosa Iodice, Enrico Tedeschi, Maria Petracca, Luigi Lavorgna, Alessandro d'Ambrosio, Vincenzo Brescia Morra, Roberta Lanzill. AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature. International journal of molecular sciences. vol 23. issue 23. 2022-12-11. PMID:36498887. |
(1) the co-occurrence of aqp4 and myelin oligodendrocyte glycoprotein (mog) antibodies in patients with demyelinating disorders is extremely rare. |
2022-12-11 |
2023-08-14 |
Not clear |
| Minghui Wu, Qi Kang, Yuezhi Kang, Yanping Tong, Tao Yang, Yongping Fa. Catalpol Regulates Oligodendrocyte Regeneration and Remyelination by Activating the GEF-Cdc42/Rac1 Signaling Pathway in EAE Mice. Evidence-based complementary and alternative medicine : eCAM. vol 2022. 2022-12-09. PMID:36482934. |
the current study aimed to investigate the direct protective effects of catalpol on demyelination damage induced by myelin oligodendrocyte glycoprotein (mog) immunization and to explore whether the gef-cdc42/rac1 signaling pathway contributes to the regeneration effect induced by catalpol. |
2022-12-09 |
2023-08-14 |
mouse |
| Jamie Jacobs, Priscilla Vu, Antonio K Li. A Patient With Myelin Oligodendrocyte Glycoprotein Positive Encephalitis With Ring Enhancing Lesions on Magnetic Resonance Imaging (MRI) After COVID-19 Exposure. Cureus. vol 14. issue 11. 2022-11-30. PMID:36447808. |
myelin oligodendrocyte glycoprotein (mog) antibody has been associated with a wide range of neurological diseases, from neuromyelitis optica spectrum disorder to acute disseminated encephalomyelitis. |
2022-11-30 |
2023-08-14 |
Not clear |
| Dariush Haghmorad, Bahman Yousefi, Majid Eslami, Ali Rashidy-Pour, Mahdieh Tarahomi, Maryam Jadid Tavaf, Azita Soltanmohammadi, Simin Zargarani, Aleksandr Kamyshnyi, Valentyn Oksenyc. Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. Current issues in molecular biology. vol 44. issue 11. 2022-11-24. PMID:36421672. |
therefore, we investigated the efficacy of oral administration of a myelin oligodendrocyte glycoprotein (mog) in the treatment of eae. |
2022-11-24 |
2023-08-14 |
mouse |
| Darius Mewes, Joseph Kuchling, Patrick Schindler, Ahmed Abdelrahim Ahmed Khalil, Sven Jarius, Friedemann Paul, Claudia Chie. Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD). Klinische Monatsblatter fur Augenheilkunde. vol 239. issue 11. 2022-11-21. PMID:36410333. |
aquaporin-4 antibody-seropositive neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad; also termed mog encephalomyelitis) are autoimmune diseases of the central nervous system. |
2022-11-21 |
2023-08-14 |
Not clear |
| Yuanhua Cai, Jocelyn A Schroeder, Weiqing Jing, Cody Gurski, Calvin B Williams, Shaoyuan Wang, Bonnie N Dittel, Qizhen Sh. Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis. Frontiers in immunology. vol 13. 2022-11-17. PMID:36389708. |
here, we report genetic engineering of hematopoietic stem cells (hscs) to express myelin oligodendrocyte glycoprotein (mog), specifically in platelets, as a means of intervention to induce immune tolerance in experimental autoimmune encephalomyelitis (eae), the mouse model of ms. |
2022-11-17 |
2023-08-14 |
mouse |